Protalix Biotherapeutics Inc. buy klostergang
Start price
08.04.15
/
50%
€18.27
Target price
08.10.15
€24.00
Performance (%)
-46.14%
End price
08.10.15
€9.84
Summary
This prediction ended on 08.10.15 with a price of €9.84. The BUY prediction by klostergang for Protalix Biotherapeutics Inc. performed very badly with a performance of -46.14%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | 0.000% | 0.000% | -12.306% | 36.737% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% | 69.888% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% | 101.814% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% | 45.300% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% | 63.763% |
Comments by klostergang for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
Protalix BioTherapeutics
Protalex recently received FDA clearance to begin a Phase 1/2 study with PRTX-100 in Immune Thrombocytopenia (ITP).
Previous data with PRTX-100 in patients with Rheumatoid Arthritis (RA) demonstrated the drug to be both safe and highly efficacious.
(Laufzeit überschritten)